Stability of vaccines during transport and storage

Inicio / Programas UE / H2020 / IMI2-2014-02-03
Logo

(IMI2-2014-02-03) - STABILITY OF VACCINES DURING TRANSPORT AND STORAGE

Programme: Horizon 2020 Framework Programme
Call: IMI2 2nd Call for proposals: IMI2 Ebola and other filoviral haemorrhagic fevers programme EU

Topic description

Scope:

Specific challenge

Currently available vaccine candidates need to be stored and transported at low temperature to maintain activity. Maintaining these conditions for deploying the vaccine in the areas targeted for vaccination can be challenging.

Scope

The project(s) will develop tools and technologies to be able to distribute current Ebola vaccine candidates utilising existing vaccine deployment infrastructure while taking into account current stability features (e.g. the need for low temperature) and also taking into account real-world field conditions and the health systems context.

Proposals that cover stability testing and supporting analytical capabilities to be applied at all stages of the shipping, storage and deployment process are encouraged.

It is considered that an IMI2 JU financial contribution of approximately 2 million and an EFPIA in-kind contribution of approximately EUR 2 million would allow this specific challenge to be addressed appropriately. Nevertheless, this does not preclude submission and selection of proposals requesting other amounts.

Expected impact

Better availability of Ebola vaccines. Novel tools and technologies for distributing current vaccines that require very low temperatures for stability.

Cross-cutting Priorities:

International cooperation

Keywords

Virology Mobile devices Research integrity and research misconduct Privacy Public Private Partnerships (PPP) Public health and epidemiology Diagnostic and implantable devices, environmental Regulatory framework for innovation Emerging Epidemics Prevention and treatment of infection by pathogens Drug development, clinical phases Viruses

Tags

Cold chain Manufacturing Ebola Adherence to vaccination regimen Biosafety level laboratory Haemorrhagic fever Filovirus Deployment of vaccines Phase I, II, III clinical trials Vaccine development Thermo-stability Diagnostics

Non atopas a financiación que precisas?

Contacta con nos e cóntanos cal é o teu proxecto.